| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 5 | +377K | 100% | $14.38 | +$5.42M |
| Sells | 0 | ||||
| Net | +5 | +377K | 100% | +$5.42M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jon Faiz Kayyem | Director | $16.3M | +$1.52M | +10.3% | Dec 16, 2024 |
| Mark Lappe | Chief Executive Officer, Director | $15.9M | +$2.42M | +18% | Sep 12, 2024 |
| Brendan P. Eckelman | Chief Scientific Officer | $6.13M | May 29, 2024 | ||
| Douglas Forsyth | Director | $3.16M | +$1.04M | +48.9% | Aug 22, 2024 |
| Viking Global Investors Lp | 10%+ Owner | $1.65M | May 29, 2024 | ||
| Kristiina Vuori | Director | $307K | +$300K | +4485% | Oct 3, 2024 |
| Kimberly Manhard | Director | $140K | +$140K | Aug 28, 2024 | |
| Kelly Deck | Chief Financial Officer | May 30, 2024 | |||
| Inhibrx, Inc. | 10%+ Owner | May 29, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|